Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis

BACKGROUND: Recently, the use of immunochemotherapy in the treatment of advanced gastric cancer (GC) has been increasing and programmed cell death protein 1 (PD-1) inhibitors combined with chemotherapy has become the first-line treatment for advanced GC. However, few studies with small sample sizes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hao, Li, Tengyun, Shao, Guoyi, Wang, Weizhi, He, Zhongyuan, Xu, Jianghao, Qian, Yawei, Liu, Hongda, Ge, Han, Wang, Linjun, Zhang, Diancai, Yang, Li, Li, Fengyuan, Xu, Zekuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326549/
https://www.ncbi.nlm.nih.gov/pubmed/37426646
http://dx.doi.org/10.3389/fimmu.2023.1193614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326549/
https://www.ncbi.nlm.nih.gov/pubmed/37426646
http://dx.doi.org/10.3389/fimmu.2023.1193614

Ejemplares similares